235 related articles for article (PubMed ID: 1580921)
1. Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer.
Pasqualini JR; Schatz B; Varin C; Nguyen BL
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):323-9. PubMed ID: 1580921
[TBL] [Abstract][Full Text] [Related]
2. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
3. Estrone sulfatase activity and effect of antiestrogens on transformation of estrone sulfate in hormone-dependent vs. independent human breast cancer cell lines.
Pasqualini JR; Nguyen BL
Breast Cancer Res Treat; 1991 May; 18(2):93-8. PubMed ID: 1912612
[TBL] [Abstract][Full Text] [Related]
4. Importance of estrogen sulfates in breast cancer.
Pasqualini JR; Gelly C; Nguyen BL; Vella C
J Steroid Biochem; 1989; 34(1-6):155-63. PubMed ID: 2560511
[TBL] [Abstract][Full Text] [Related]
5. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and biologic response of estrogen sulfates in hormone-dependent and hormone-independent mammary cancer cell lines. Effect of antiestrogens.
Pasqualini JR; Gelly C; Nguyen BL
Ann N Y Acad Sci; 1990; 595():106-16. PubMed ID: 2375600
[TBL] [Abstract][Full Text] [Related]
7. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
[TBL] [Abstract][Full Text] [Related]
8. Control of sulfatase and sulfotransferase activities by medrogestone in the hormone-dependent MCF-7 and T-47D human breast cancer cell lines.
Chetrite GS; Ebert C; Wright F; Philippe AC; Pasqualini JR
J Steroid Biochem Mol Biol; 1999; 70(1-3):39-45. PubMed ID: 10529001
[TBL] [Abstract][Full Text] [Related]
9. Effect of promegestone, tamoxifen, 4-hydroxytamoxifen and ICI 164,384 on the oestrone sulphatase activity of human breast cancer cells.
Chetrite G; Varin C; Delalonde L; Pasqualini JR
Anticancer Res; 1993; 13(4):931-4. PubMed ID: 8352561
[TBL] [Abstract][Full Text] [Related]
10. The SEEM: selective estrogen enzyme modulators in breast cancer.
Pasqualini JR; Ebert C; Chetrite GS
Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():1-8. PubMed ID: 10862262
[TBL] [Abstract][Full Text] [Related]
11. Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence.
Pasqualini JR; Chetrite G; Nguyen BL; Maloche C; Delalonde L; Talbi M; Feinstein MC; Blacker C; Botella J; Paris J
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):407-12. PubMed ID: 7626488
[TBL] [Abstract][Full Text] [Related]
12. Progestins and breast cancer.
Pasqualini JR
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
[TBL] [Abstract][Full Text] [Related]
13. Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells.
Nguyen BL; Ferme I; Chetrite G; Pasqualini JR
J Steroid Biochem Mol Biol; 1993 Jul; 46(1):17-23. PubMed ID: 8338787
[TBL] [Abstract][Full Text] [Related]
14. Estradiol as an anti-aromatase agent in human breast cancer cells.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2006 Jan; 98(1):12-7. PubMed ID: 16413774
[TBL] [Abstract][Full Text] [Related]
15. Control and expression of oestrone sulphatase activities in human breast cancer.
Pasqualini JR; Chetrite G; Nestour EL
J Endocrinol; 1996 Sep; 150 Suppl():S99-105. PubMed ID: 8943793
[TBL] [Abstract][Full Text] [Related]
16. Estrogen sulfatase and estrogen sulfotransferase in human primary mammary carcinoma.
Tseng L; Mazella J; Lee LY; Stone ML
J Steroid Biochem; 1983 Oct; 19(4):1413-7. PubMed ID: 6580511
[TBL] [Abstract][Full Text] [Related]
17. Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020).
Nguyen BL; Chetrite G; Pasqualini JR
Breast Cancer Res Treat; 1995 May; 34(2):139-46. PubMed ID: 7647331
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
Selcer KW; Jagannathan S; Rhodes ME; Li PK
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
[TBL] [Abstract][Full Text] [Related]
19. The selective estrogen enzyme modulators in breast cancer: a review.
Pasqualini JR
Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
[TBL] [Abstract][Full Text] [Related]
20. Human estrogen sulfotransferase (hEST1) activities and its mRNA in various breast cancer cell lines. Effect of the progestin, promegestone (R-5020).
Chetrite G; Le Nestour E; Pasqualini JR
J Steroid Biochem Mol Biol; 1998 Sep; 66(5-6):295-302. PubMed ID: 9749835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
